AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19841299 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intravenously 30 to 90 minutes before and ending 4 hours after the procedure
Number of subjects: 208
Study 19841299 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost
Number of subjects: 208
Study 19841299 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 208
Study 17078183 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term inpatient care
Number of subjects: 6614
Study 17078183 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term inpatient care
Number of subjects: 6614
Study 17078183 — intervention group
Group type: EXPERIMENTAL
Intervention: High costs for hospital care
Number of subjects: 6614
Study 17078183 — intervention group
Group type: EXPERIMENTAL
Intervention: High costs for nursing home care
Number of subjects: 6614
Study 14745710 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 79
Study 11728949 — intervention group
Group type: EXPERIMENTAL
Intervention: Bgl II polymorphism of the alpha2beta1 integrin gene
Number of subjects: 234
Study 11728949 — intervention group
Group type: EXPERIMENTAL
Intervention: Bgl II+ allele of the alpha2beta1 integrin
Number of subjects: 234
Study 11728949 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, duration of diabetes, BMI, and HbA(1c) level
Number of subjects: 234
Study 11728949 — intervention group
Group type: EXPERIMENTAL
Intervention: Bgl II polymorphism of the alpha2beta1 integrin gene and Apa I polymorphism of the platelet GPIIIa gene
Number of subjects: 234
Study 9613374 — intervention group
Group type: EXPERIMENTAL
Intervention: Reoperation
Number of subjects: 47
Study 9613374 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin injection
Number of subjects: 47
Study 8296736 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 94
Study 2487463 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose oral amoxicillin
Number of subjects: 50
Study 2487463 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose TMP-SMX (2 tablets DS)
Number of subjects: 50
Study 2487463 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose ofloxacin (400 mg)
Number of subjects: 50
Study 1105693 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-amniotic injection of 2.5 mg of 15(S)-15-methyl-prostaglandin F2alpha
Number of subjects: 55
Study 1105693 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 15(S)-15-methyl-prostaglandin F2alpha (200 mug initially and 300 mug every third hour until 30 hrs or abortion)
Number of subjects: 55
Study 31301741 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular exercise (twice a week for 60 minutes over 6 months)
Number of subjects: 219
Study 29051218 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of glucose/GA ratio
Number of subjects: 3026
Study 29051218 — intervention group
Group type: COMPARATOR
Intervention: Lowest quartile of glucose/GA ratio
Number of subjects: 3026
Study 26618460 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A (Speywood Unit; s.U) and HA fillers
Number of subjects: 0
Study 23467108 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube cecostomy (Group A)
Number of subjects: 156
Study 23467108 — intervention group
Group type: COMPARATOR
Intervention: Loop colostomy (Group B)
Number of subjects: 156
Study 22241951 — intervention group
Group type: COMPARATOR
Intervention: Insulin-stimulated endothelial function in patients with systolic heart failure
Number of subjects: 59
Study 22241951 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-stimulated endothelial function in healthy controls
Number of subjects: 59
Study 22241951 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-stimulated endothelial function in patients with both heart failure and diabetes
Number of subjects: 59
Study 22241951 — intervention group
Group type: COMPARATOR
Intervention: Forearm glucose uptake in patients with heart failure
Number of subjects: 59
Study 22241951 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm glucose uptake in patients with both heart failure and diabetes
Number of subjects: 59
Study 17629442 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (DSF)
Number of subjects: 100
Study 17629442 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 100
Study 17038057 — intervention group
Group type: EXPERIMENTAL
Intervention: Siwak
Number of subjects: 40
Study 17038057 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Siwak and orthodontic toothbrush
Number of subjects: 40
Study 17038057 — intervention group
Group type: EXPERIMENTAL
Intervention: Siwak (used solely)
Number of subjects: 40
Study 17038057 — intervention group
Group type: EXPERIMENTAL
Intervention: Siwak (in combination with orthodontic toothbrush)
Number of subjects: 40
Study 17038057 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 40
Study 17038057 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic toothbrush
Number of subjects: 40
Study 12675949 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Based Learning (PBL)
Number of subjects: 112
Study 12675949 — intervention group
Group type: COMPARATOR
Intervention: Lecture-Based Learning (LBL)
Number of subjects: 112
Study 12198777 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus duration
Number of subjects: 0
Study 12198777 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus contrast
Number of subjects: 0
Study 12198777 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of a blank gap between successive presentations
Number of subjects: 0
Study 12198777 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence or absence of a noise mask
Number of subjects: 0
Study 7782903 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet low in folate and exogenous methyl groups, soy-product-amino acid defined diet for 45 d, 25 micrograms/d of folate for 30 d, 99 micrograms/d for 15 d, supplemented with methionine for half the subjects.
Number of subjects: 10
Study 7782903 — intervention group
Group type: EXPERIMENTAL
Intervention: Low methionine and choline diet supplemented with methionine for half the subjects.
Number of subjects: 10
Study 7782903 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary restriction of methyl groups (low methionine and choline).
Number of subjects: 10
Study 1776352 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrograde Venous Perfusion (RVP) treatment
Number of subjects: 20
Study 1776352 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) treated with systemic i.v. infusions
Number of subjects: 20
Study 1776352 — intervention group
Group type: EXPERIMENTAL
Intervention: RVP treatment in patients with secondary osteomyelitis
Number of subjects: 20
Study 1776352 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with secondary osteomyelitis
Number of subjects: 20
Study 1776352 — intervention group
Group type: EXPERIMENTAL
Intervention: RVP treatment
Number of subjects: 20
Study 1776352 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study 6894606 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous killed poliovirus vaccine
Number of subjects: 2
Study 6894606 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous poliovirus vaccination
Number of subjects: 2
Study 6894606 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroral liver poliovirus vaccine
Number of subjects: 2
Study 6894606 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroral liver poliovirus vaccine with subcutaneous killed Vibrio cholerae vaccine
Number of subjects: 2
Study 6199764 — intervention group
Group type: EXPERIMENTAL
Intervention: VDD pacing (Medtronic #2409, ASVIP)
Number of subjects: 8
Study 6199764 — intervention group
Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 8
Study 6199764 — intervention group
Group type: EXPERIMENTAL
Intervention: VDD pacing
Number of subjects: 8
Study 26856360 — intervention group
Group type: EXPERIMENTAL
Intervention: Knew the victim or perpetrator (SA scenario)
Number of subjects: 721
Study 26856360 — intervention group
Group type: EXPERIMENTAL
Intervention: Knew the victim or perpetrator (IPV scenario)
Number of subjects: 721
Study 26856360 — intervention group
Group type: EXPERIMENTAL
Intervention: Knew neither the victim nor the perpetrator (both scenarios)
Number of subjects: 721
Study 26856360 — intervention group
Group type: EXPERIMENTAL
Intervention: Men (SA scenario)
Number of subjects: 721
Study 26856360 — intervention group
Group type: EXPERIMENTAL
Intervention: Women (IPV scenario)
Number of subjects: 721
Study 26253887 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 g intraoperatively and 15 mg/kg for an additional 3 days)
Number of subjects: 118
Study 26253887 — intervention group
Group type: COMPARATOR
Intervention: Control group (no methylprednisolone)
Number of subjects: 118
Study 24535350 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber post and core with normal alveolar bone height (Group A)
Number of subjects: 48
Study 24535350 — intervention group
Group type: EXPERIMENTAL
Intervention: Ni-Cr cast post and core with normal alveolar bone height (Group B)
Number of subjects: 48
Study 24535350 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber post and core with 2 mm alveolar bone height reduction (Group C)
Number of subjects: 48
Study 24535350 — intervention group
Group type: EXPERIMENTAL
Intervention: Ni-Cr cast post and core with 2 mm alveolar bone height reduction (Group D)
Number of subjects: 48
Study 24535350 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber post and core with 4 mm alveolar bone height reduction (Group E)
Number of subjects: 48
Study 24535350 — intervention group
Group type: EXPERIMENTAL
Intervention: Ni-Cr cast post and core with 4 mm alveolar bone height reduction (Group F)
Number of subjects: 48
Study 22684738 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil Ce = 2 ng ml(‐1)
Number of subjects: 18
Study 22684738 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil Ce = 4 ng ml(‐1)
Number of subjects: 18
Study 22684738 — intervention group
Group type: EXPERIMENTAL
Intervention: CARDEAN > 60 during surgery
Number of subjects: 18
Study 19816214 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching for 10 minutes with a 30-second hold
Number of subjects: 10
Study 19816214 — intervention group
Group type: COMPARATOR
Intervention: No static stretching (control)
Number of subjects: 10
Study 17084395 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG administration during IVF cycles
Number of subjects: 844
Study 17084395 — intervention group
Group type: EXPERIMENTAL
Intervention: Declining E(2) levels after hCG administration
Number of subjects: 844
Study 15692762 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin 75 mg/M2 q2 wks x 3 and docetaxel 40 mg/M2 weekly x 6
Number of subjects: 70
Study 15692762 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin and docetaxel
Number of subjects: 70
Study 12427893 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta‐1a (IFNbeta‐1a)
Number of subjects: 172
Study 12427893 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion volumes measured during the original trial
Number of subjects: 172
Study 10599371 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauredon (50 mg/week intramuscularly)
Number of subjects: 40
Study 7556989 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide 1.25 mg
Number of subjects: 13
Study 7556989 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide 5.0 mg
Number of subjects: 13
Study 2031637 — intervention group
Group type: EXPERIMENTAL
Intervention: Thumb and index finger grip
Number of subjects: 16
Study 2031637 — intervention group
Group type: COMPARATOR
Intervention: Whole hand technique
Number of subjects: 16
Study 6110384 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg or 30 mg orally 1 hour before surgery
Number of subjects: 60
Study 6110384 — intervention group
Group type: COMPARATOR
Intervention: Placebo of identical appearance
Number of subjects: 60
Study 31577875 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy for 28 weeks (immediate group)
Number of subjects: 956
Study 31577875 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid preventive therapy for 28 weeks (deferred group)
Number of subjects: 956
Study 31577875 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (immediate group)
Number of subjects: 956
Study 31577875 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (deferred group)
Number of subjects: 956
Study 29632870 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine D2/D3 receptor antagonist sulpiride
Number of subjects: 37
Study 29632870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 26657824 — intervention group
Group type: EXPERIMENTAL
Intervention: Loulla (liquid formulation of 6-mercaptopurine)
Number of subjects: 15
Study 26657824 — intervention group
Group type: COMPARATOR
Intervention: Registered tablets (control)
Number of subjects: 15
Study 25320240 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 5924
Study 25320240 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 5924
Study 22288567 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2248761
Number of subjects: 0
Study 19594606 — intervention group
Group type: EXPERIMENTAL
Intervention: Late leakage (LL) group
Number of subjects: 234
Study 19594606 — intervention group
Group type: COMPARATOR
Intervention: No leakage (NL) group
Number of subjects: 234
Study 17656827 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine 20mg/day
Number of subjects: 470
Study 17656827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 470
Study 15659587 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart and Soul Physical Activity Program (HSPAP)
Number of subjects: 42
Study 15659587 — intervention group
Group type: COMPARATOR
Intervention: Comparison groups
Number of subjects: 42
Study 12378877 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychopharmacotherapy combined with cognitive behavioural therapy
Number of subjects: 40
Study 12378877 — intervention group
Group type: COMPARATOR
Intervention: Psychopharmacotherapy only
Number of subjects: 40
Study 10594487 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg diclofenac
Number of subjects: 30
Study 10594487 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg disulfiram
Number of subjects: 30
Study 10594487 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg itraconazole
Number of subjects: 30
Study 10594487 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 ml grapefruit juice twice daily
Number of subjects: 30
Study 10594487 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg erythromycin 4 times daily
Number of subjects: 30
Study 7565149 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition with varying ability to understand sexual relationship concepts
Number of subjects: 4
Study 7565149 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 4
Study 1950721 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu200 IUD with marker strings
Number of subjects: 1265
Study 1950721 — intervention group
Group type: COMPARATOR
Intervention: TCu200 IUD without marker strings
Number of subjects: 1265
Study 1950721 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1265
Study 6753912 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 221
Study 29267900 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic nomograms for one-year overall survival
Number of subjects: 22674
Study 29267900 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic nomograms for six-month progression-free survival
Number of subjects: 22674
Study 26874645 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (15 mg/d, titrated to 30 or 60 mg/d)
Number of subjects: 57
Study 26874645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 25278086 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV Commercial lot
Number of subjects: 466
Study 25278086 — intervention group
Group type: COMPARATOR
Intervention: PHiD-CV Clinical lot
Number of subjects: 466
Study 25278086 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV
Number of subjects: 466
Study 22740283 — intervention group
Group type: EXPERIMENTAL
Intervention: BICON-PLUS NT acetabular cup
Number of subjects: 0
Study 22740283 — intervention group
Group type: COMPARATOR
Intervention: BICON-PLUS acetabular cup
Number of subjects: 0
Study 19554028 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower intensity training (33% of HR reserve)
Number of subjects: 0
Study 19554028 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity training (66% of HR reserve)
Number of subjects: 0
Study 19554028 — intervention group
Group type: COMPARATOR
Intervention: Control (sedentary period)
Number of subjects: 0
Study 17506866 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardio-selective beta(1)-adrenergic blockade (0.15 mg kg(‐1) metoprolol)
Number of subjects: 8
Study 17506866 — intervention group
Group type: COMPARATOR
Intervention: Moderate (105 +/- 11 W) and heavy (162 +/- 8 W) intensity cycling
Number of subjects: 8
Study 16298888 — intervention group
Group type: EXPERIMENTAL
Intervention: Short study time with original context reinstated
Number of subjects: 456
Study 16298888 — intervention group
Group type: EXPERIMENTAL
Intervention: Long study time with original context reinstated
Number of subjects: 456
Study 16298888 — intervention group
Group type: COMPARATOR
Intervention: Short study time without original context reinstated
Number of subjects: 456
Study 16298888 — intervention group
Group type: COMPARATOR
Intervention: Long study time without original context reinstated
Number of subjects: 456
Study 16298888 — intervention group
Group type: COMPARATOR
Intervention: No contextual or inter-item associative cues
Number of subjects: 456
Study 11927516 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of concentrated ambient fine particles (CAP) plus ozone (120 ppb) for 2 hours
Number of subjects: 25
Study 11927516 — intervention group
Group type: COMPARATOR
Intervention: Filtered air inhalation
Number of subjects: 25
Study 9583759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse clinician‐mediated intervention including pain assessment, education about pain control, patient empowerment, and communication with healthcare providers.
Number of subjects: 4804
Study 9583759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse clinician‐mediated intervention
Number of subjects: 4804
Study 9583759 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 4804
Study 8137988 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment to induce immunosuppression
Number of subjects: 111
Study 8137988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 2683546 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia (Group I, n = 29)
Number of subjects: 80
Study 2683546 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia (Group II, n = 29)
Number of subjects: 80
Study 2683546 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia with lower isoflurane concentration (Group III, n = 22)
Number of subjects: 80
Study 30456542 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic TKA
Number of subjects: 351
Study 30456542 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 351
Study 26525835 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular training (CT)
Number of subjects: 63
Study 26525835 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 63
Study 26525835 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 63
Study 26525835 — intervention group
Group type: EXPERIMENTAL
Intervention: Both training programs (CT and RT)
Number of subjects: 63
Study 24671637 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative exercise
Number of subjects: 72
Study 24671637 — intervention group
Group type: COMPARATOR
Intervention: Surgery-alone
Number of subjects: 72
Study 22032343 — intervention group
Group type: EXPERIMENTAL
Intervention: Catechin-rich green tea plus inulin
Number of subjects: 30
Study 22032343 — intervention group
Group type: COMPARATOR
Intervention: Control group (650 ml tea)
Number of subjects: 30
Study 20176314 — intervention group
Group type: EXPERIMENTAL
Intervention: Very brief (30-second) smoking intervention
Number of subjects: 295
Study 20176314 — intervention group
Group type: COMPARATOR
Intervention: Control no-intervention condition
Number of subjects: 295
Study 18951004 — intervention group
Group type: EXPERIMENTAL
Intervention: High-DHA milk (1% total fat as DHA)
Number of subjects: 0
Study 18951004 — intervention group
Group type: COMPARATOR
Intervention: Standard-DHA milk (0.2-0.3% DHA)
Number of subjects: 0
Study 16911649 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical racemic adrenaline (RA) 1:500
Number of subjects: 93
Study 16911649 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (physiological saline)
Number of subjects: 93
Study 14719288 — intervention group
Group type: EXPERIMENTAL
Intervention: Da Ding Feng Zhu Decoction
Number of subjects: 56
Study 14719288 — intervention group
Group type: COMPARATOR
Intervention: Colchicine
Number of subjects: 56
Study 11110056 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg toremifene
Number of subjects: 141
Study 11110056 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg tamoxifen
Number of subjects: 141
Study 11110056 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant systemic therapy
Number of subjects: 141
Study 11110056 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 141
Study 8986909 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50-100 mg)
Number of subjects: 20
Study 8986909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7708425 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained paraplegics (TP) in hot climate (37 degrees C)
Number of subjects: 10
Study 7708425 — intervention group
Group type: COMPARATOR
Intervention: Able-bodied subjects (AB) in hot climate (37 degrees C)
Number of subjects: 10